The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Gene silencing as a threat to the success of gene therapy
Abstract
Eukaryotes deploy elaborate defensive systems to protect the structure of their genomes and to oppose the expression of abnormal or alien transcription units. In mammals, the insertion of retroviral DNA or the incorporation of repeat arrays can trigger transcriptional silencing of the inserted sequences, usually via mechanisms that involve methylation of DNA within regulatory regions. Fungi and plants have similar methylation-based systems and also employ diverse post-transcriptional mechanisms to reduce or eliminate the expression of alien transcription units, mechanisms that operate even in organisms that apparently lack the capacity to methylate their DNA. Given their ubiquity in other eukaryotes, it is likely that similar post-transcriptional silencing mechanisms will be found to operate in mammals as well. I argue here that gene silencing mechanisms are diverse and efficient and are likely to represent a barrier to many forms of gene therapy. For this reason, it will be necessary to develop gene therapy vectors that are both resistant to host defensive measures and efficient in terms of delivery and expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This can result in an increase of expression and off-target effects, or even potential damage to the cell if the insertion randomly occurs within an important cellular protein (Bestor, 2000; Papapetrou and Schambach, 2016).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Bestor, 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeat-induced gene silencing in mammals
Garrick, D., Fiering, S., Martin, D. I. K., & Whitelaw, E. (1998) · Nature Genetics · doi:10.1038/ng0198-56 · Cited by 887 · cited 1×
“(14) showed that a repeat array upstream of a reporter gene in transgenic mice caused methylation and silencing of the transgene; removal of the array via Cre-mediated excision relieved the silencing and reduced methylation of the transgene promoter.”
BackgroundDe novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
Lei, H., Oh, S. P., Okano, M., Jüttermann, R., Goss, K. A., Jaenisch, R., & Li, E. (1996) · Development · doi:10.1242/dev.122.10.3195 · Cited by 816
Research works printed but not linked: 19
- Bestor, 1994, Dev Genet, 15, 458, 10.1002/dvg.1020150603 · DOI
- Yoder, 1997, Trends Genet, 13, 335, 10.1016/S0168-9525(97)01181-5 · DOI · Paper page
- Berleth, 1987, J Gen Virol, 68, 2919, 10.1099/0022-1317-68-11-2919 · doi:10.1099/0022-1317-68-11-2919
- Bestor, 1996, Nat Genet, 12, 363, 10.1038/ng0496-363 · DOI · Paper page
- Wolffe, 1999, Science, 286, 481, 10.1126/science.286.5439.481 · DOI · Paper page
- Jaenisch, 1986, Proc Natl Acad Sci USA, 82, 1451, 10.1073/pnas.82.5.1451 · DOI
- Palmer, 1991, Proc Natl Acad Sci USA, 88, 1330, 10.1073/pnas.88.4.1330 · DOI · Paper page
- Wei, 1999, Gene Ther, 6, 840, 10.1038/sj.gt.3300878 · doi:10.1038/sj.gt.3300878
- Halene, 1999, Blood, 94, 3349, 10.1182/blood.V94.10.3349.422k05_3349_3357 · DOI
- Selker, 1997, Trends Genet, 13, 296, 10.1016/S0168-9525(97)01201-8 · DOI · Paper page
- Matzke, 1998, Curr Opin Plant Biol, 1, 142, 10.1016/S1369-5266(98)80016-2 · DOI · Paper page
- Mehtali, 1990, Gene, 91, 179, 10.1016/0378-1119(90)90086-7 · DOI
- Dorer, 1997, Genetics, 147, 1181, 10.1093/genetics/147.3.1181 · DOI · Paper page
- Scrable, 1997, Genetics, 147, 297, 10.1093/genetics/147.1.297 · DOI
- Hamilton, 1999, Science, 286, 950, 10.1126/science.286.5441.950 · DOI · Paper page
- Tuschl, 1999, Genes Dev, 13, 3191, 10.1101/gad.13.24.3191 · DOI · Paper page
- Wianny, 2000, Nat Cell Biol, 2, 70, 10.1038/35000016 · DOI · Paper page
- Xu, 1997, Nat Genet, 17, 376, 10.1038/ng1297-376 · DOI · Paper page
- Harvey, 1999, J Clin Invest, 104, 1245, 10.1172/JCI7935 · DOI · Paper page
Cited by
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
Demaison, C., Parsley, K., Brouns, G., Scherr, M., Battmer, K., Kinnon, C., Grez, M., & Thrasher, A. J. (2002) · Human Gene Therapy · doi:10.1089/10430340252898984 · Cited by 486
Jordan, A., Defechereux, P., & Verdin, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1726 · Cited by 467
Safe harbours for the integration of new DNA in the human genome
Sadelain, M., Papapetrou, E. P., & Bushman, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3179 · Cited by 441
Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
Papapetrou, E. P., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.38 · Cited by 238
Metadata
- Authors
- Bestor, T. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-15
- Volume
- 105
- Issue
- 4
- Pages
- 409-411
- ISSN
- 0021-9738
- Cited by
- 154
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene silencing as a threat to the success of gene therapy. https://app.cochat.ai/papers/10.1172/jci9459
- The paper
- Bestor, T. H. (2000). Gene silencing as a threat to the success of gene therapy. Journal of Clinical Investigation. https://doi.org/10.1172/jci9459
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.